imatinib mesylate has been researched along with Carcinoma, Neuroendocrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astsaturov, I; Boland, P; Cohen, SJ; Engstrom, P; Olszanski, AJ; Perkins, J; Zhou, Y | 1 |
Aschoff, AJ; Henne-Bruns, D; Kramer, K; Siech, M; Sträter, J | 1 |
Ishiwata, T; Kanazawa, Y; Koizumi, M; Naito, Z; Nakazawa, N; Ohaki, Y; Seya, T; Shinji, S; Tajiri, T; Takahashi, Y; Tanaka, N; Teranishi, N; Yamada, T; Yokoi, K | 1 |
3 other study(ies) available for imatinib mesylate and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case study.
Topics: Benzamides; Carcinoma, Neuroendocrine; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kinesins; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Signal Transduction | 2014 |
[GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) + neurofibromatosis (NF) -- case report and review of the literature].
Topics: Adult; Antineoplastic Agents; Benzamides; Carcinoma, Neuroendocrine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Duodenal Neoplasms; Duodenum; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Jejunal Neoplasms; Neurofibromatosis 1; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Shock, Hemorrhagic; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2005 |
Pathological and biomolecular analyses of colorectal endocrine carcinoma.
Topics: Benzamides; Carcinoma, Neuroendocrine; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Vascular Endothelial Growth Factor A | 2007 |